A novel study has shown that Senolytics, a new class of drugs, have the potential to prevent the transfer of senescence, a key mechanism of aging, and the associated physical and cognitive impairments ...
PARP inhibitors are a drug class that has become an important therapeutic for ovarian and some other cancers. This study looked at pretreatment biopsies to define predictors of response to treatment ...
A study of the lead agent (CPI-613) in a class of anticancer drugs undergoing Food and Drug Administration (FDA) approved clinical trials reveals that CPI-613 is effective against most carcinoma cell ...
Researchers at Weill Cornell Medicine have discovered how drugs can affect various membrane-spanning proteins in addition to their intended target, potentially causing unwanted side effects. The ...
A first-in-class drug engineered to selectively inhibit the signaling pathway of the cannabinoid receptor CB1 has shown promise as a safe and effective treatment for cannabis use disorder (CUD). Tests ...
Established drugs were repurposed, “me-too” drugs were approved, and even the few new biological approaches lacked clinical ...
Dealbreaker on MSN
Startup Fortitude Bio launches to beat drug resistance in cancer, expand ADCs to autoimmune disease
The company joins a group of degrader ADC (or DAC) developers that includes Bristol Myers Squibb and Pfizer.
Dublin, July 07, 2020 (GLOBE NEWSWIRE) -- The "Europe Antibiotics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class; Action Mechanism; and Country" report has been added to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results